Ghost Tree Capital’s Allergan plc AGN Stock Holding History

Ghost Tree Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-75,000	Closed	-$12.3M	–	72
2017 Q4	$12.3M	Buy	+75,000	New	+$13.5M	2.88%	9

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ghost Tree Capital's AGN Position: Q2 2018 in Review

Ghost Tree Capital sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 45,000 shares — an estimated $7.57M sold.

Ghost Tree Capital first reported a position in AGN in Q2 2014 and held it in 8 quarters. The position peaked at $13.7M in Q2 2015. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

Ghost Tree Capital reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
Ghost Tree Capital sold 45,000 Allergan plc shares in Q2 2018, an estimated $7.57M.
Ghost Tree Capital first reported a position in Allergan plc in Q2 2014 and held it in 8 quarters.
Ghost Tree Capital's Allergan plc position peaked at $13.7M in Q2 2015.
1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Ghost Tree Capital's 13F filing for Q2 2018, filed 14 Aug 2018.